Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) [Phase 3]

View source ↗

Summary

A Phase 3 trial update assessing the safety and tolerability of MK0217 in women with postmenopausal osteoporosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• MK0217

Snippet

Sponsor: Organon and Co | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED